Effects of Replacing Diet Beverages With Water on Weight Loss and Plasma Glucose Control in Type 2 Diabetes

Sponsor
Novindiet Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT02412774
Collaborator
University of Nottingham (Other), Tehran University of Medical Sciences (Other)
81
1
2
9
9

Study Details

Study Description

Brief Summary

The purpose of the present study is to evaluate the effect of replacing diet beverages with water on weight loss and biochemical indicators for insulin sensitivity and cardiometabolic risk factors of diabetic obese and overweight female adults when they are in a multidisciplinary weight loss plan.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: DBs at the end of the main meal + Diet
  • Behavioral: Water at the end of the main meal+ Diet
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
81 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Replacing Diet Beverages With Water on Type 2 Diabetic Obese Females Attending a Weight Loss Program - a Randomized, 24 Week Clinical Trial
Actual Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Oct 1, 2015
Actual Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Diet Beverages (DBs)

Diet beverages after the main meal+ Diet

Behavioral: DBs at the end of the main meal + Diet
Subjects are asked to have 250 ml DBs at the end of their lunch as the main meal, while they are on a multidisciplinary diet plan for 24 weeks.

Experimental: Water

Water after the main meal+ Diet

Behavioral: Water at the end of the main meal+ Diet
Subjects are asked to have 250 ml water at the end of their lunch as the main meal, while they are on a multidisciplinary diet plan for 24 weeks.

Outcome Measures

Primary Outcome Measures

  1. Weight loss [24 weeks]

Secondary Outcome Measures

  1. Fasting plasma glucose [24 weeks]

  2. Insulin resistance (HOMA) [24 weeks]

  3. Lipid profiles [24 weeks]

  4. Waist circumference [24 weeks]

  5. BMI [24 Weeks]

  6. HA1C [24 Weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diabetic female patient with 6.5<H1AC<7.2.

  • Monotherapy with Metformin.

  • 18-45 years of age.

  • Body mass index (BMI) between 27-35 kg/ m².

  • Consume DBs regularly during their habitual diet.

  • Must be able to have moderate exercise.

  • Must be interested to have weight loss.

Exclusion Criteria:
  • Participating in a research project involving weight loss or physical activity in the previous six months.

  • Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months.

  • Taking medication that could affect metabolism or change body weight.

  • Report heart problems, chest pain, and cancer within the last five years.

  • Unwilling to change intake of beverages during the study period.

Contacts and Locations

Locations

Site City State Country Postal Code
1 NovinDiet Clinic Tehran Iran, Islamic Republic of 1913635136

Sponsors and Collaborators

  • Novindiet Clinic
  • University of Nottingham
  • Tehran University of Medical Sciences

Investigators

  • Study Chair: Hamid R Farshchi, MD, PhD, NovinDiet Clinic, School of Life Sciences, The University of Nottingham
  • Principal Investigator: Ameneh Madjd, Dr, NovinDiet Clinic, School of Life Sciences, The University of Nottingham
  • Principal Investigator: Ian A Macdonald, Prof., School of Life Sciences, The University of Nottingham
  • Principal Investigator: Moira A Taylor, PhD, School of Life Sciences, The University of Nottingham
  • Principal Investigator: Reza Malekzadeh, Prof., Digestive Disease Research Institute, Tehran University of Medical Sciences
  • Principal Investigator: Alireza Delavari, MD, Digestive Disease Research Institute, Tehran University of Medical Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Novindiet Clinic
ClinicalTrials.gov Identifier:
NCT02412774
Other Study ID Numbers:
  • ND-107
First Posted:
Apr 9, 2015
Last Update Posted:
Oct 25, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Novindiet Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2019